NASDAQ:KALV

Kalvista Pharmaceuticals Stock Forecast

etoro logo Buy KALV
*Your capital is at risk
$14.86
+1.24 (+9.10%)
At Close: Nov 17, 2025
AI Analysis AI Analysis of KALV
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

High volatility in KalVista Pharmaceuticals Inc stock price on Monday which ended trading at $14.86
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Nov 11, 2025 Gain 29.56%

The KalVista Pharmaceuticals Inc stock price gained 9.10% on the last trading day (Monday, 17th Nov 2025), rising from $13.62 to $14.86. During the last trading day the stock fluctuated 12.39% from a day low at $13.32 to a day high of $14.97. The price has risen in 6 of the last 10 days and is up by 37.59% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 million more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately $45.39 million.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $13.59, a level that may pose a second chance to hit a runner. According to fan-theory $16.85 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

KALV Signals & Forecast

Mostly positive signals in the chart today. The KalVista Pharmaceuticals Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $12.58 and $11.55. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, November 04, 2025, and so far it has risen 38.10%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for KalVista Pharmaceuticals Inc stock

On the downside, the stock finds support just below today's level from accumulated volume at $13.34 and $12.10. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, KalVista Pharmaceuticals Inc finds support just below today's level at $13.34. If this is broken, then the next support from accumulated volume will be at $12.10 and $11.47.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.65 between high and low, or 12.39%. For the last week, the stock has had daily average volatility of 10.34%.

The KalVista Pharmaceuticals Inc stock is extremely overbought on RSI14 (84). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.

Our recommended stop-loss: $14.37 (-3.32%) (This stock has high daily movements and this gives high risk. The RSI14 is 84 and this increases the risk substantially. There is a buy signal from a pivot bottom found 9 days ago.)

Trading Expectations (KALV) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect KalVista Pharmaceuticals Inc to open at $14.38, and during the day (based on 14 day Average True Range), to move between $14.49 and $15.23, which gives a possible trading interval of +/-$0.746 (+/-5.15%) up or down from last closing price. If KalVista Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 5.15% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $15.20 (2.29%) than the support at $13.34 (10.23%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is KalVista Pharmaceuticals Inc stock A Buy?

KalVista Pharmaceuticals Inc holds several positive signals and the break up from the falling trend indicates a possible shift of trend as well. The trend doesn't have to go from falling to rising, it may as well go horizontal or even just decrease the earlier fall rate, but we find the risk-reward to be attractive and expect the stock to perform very well in the short term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

Current score: 5.663 Strong Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $14.38 ( 3.21%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

KALV Performance

Trading levels for KALV

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 16.03 7.90%
R2 15.40 3.65%
R1 15.01 1.03%
Price 14.86
S1 13.75 -7.45%
S2 13.36 -10.07%
S3 12.73 -14.31%

Accumulated Volume Support & Resistance Levels

Level Price
R3 15.96 7.40%
R2 15.61 5.05%
R1 15.20 2.29%
Price 14.86
S1 13.34 -10.23%
S2 12.10 -18.61%
S3 11.47 -22.81%

FAQ

What is the symbol for KalVista Pharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for KalVista Pharmaceuticals Inc is KALV and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell KalVista Pharmaceuticals Inc Stock?
KalVista Pharmaceuticals Inc holds several positive signals and the break up from the falling trend indicates a possible shift of trend as well. The trend doesn't have to go from falling to rising, it may as well go horizontal or even just decrease the earlier fall rate, but we find the risk-reward to be attractive and expect the stock to perform very well in the short term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

How to buy KalVista Pharmaceuticals Inc Stock?
KalVista Pharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy KalVista Pharmaceuticals Inc Stock.

What's the current price of KalVista Pharmaceuticals Inc Stock?
As of the end of day on the Nov 17, 2025, the price of an KalVista Pharmaceuticals Inc (KALV) share was $14.86.

What is the 52-week high and low for KalVista Pharmaceuticals Inc Stock?
The 52-week high for KalVista Pharmaceuticals Inc Stock is $17.28 and the 52-week low is $7.30.

What is the market capitalization of KalVista Pharmaceuticals Inc Stock?
As of the Nov 17, 2025, the market capitalization of KalVista Pharmaceuticals Inc is 751.118M.

When is the next earnings date for KalVista Pharmaceuticals Inc?
The upcoming earnings date for KalVista Pharmaceuticals Inc is Dec 11, 2025.
Click to get the best stock tips daily for free!
ABOUT KALVISTA PHARMACEUTICALS INC
KalVista Pharmaceuticals
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed ...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE